AbbVie Prepares for Imbruvica Price Negotiations with $2.1 Billion Charge
AbbVie Prepares for Imbruvica: AbbVie, a pharmaceutical company, is bracing itself for upcoming government price negotiations that could affect its lucrative cancer drug, Imbruvica. In preparation for the anticipated revenue […]